To add to this complexity, recent work from our group has shown that carriage of the primary genetic risk factor for MS, HLA‐DRB1*15, influences the extent of cortical microglial inflammation in younger cases [14, 15]. Here, HLA-DRB1 is linked to myeloid sarcoma.